Shareholder Information


TSX Venture Exchange


Share Capital as at June 30, 2020

Issued Shares 28.5 million
Fully Diluted Shares 51.4 million

Stock Quote

The NeuPath common shares started trading on the TSX Venture Exchange on July 6, 2020.
Registered shareholders with questions regarding share certificates, change of address for your account or share transfers should contact:

Transfer Agent

TSX Trust Company
301-100 Adelaide Street West
Toronto, ON M5H 4H1
(416) 361-0930

Independent Auditors

Ernst & Young LLP
100 Adelaide Street West
Toronto, ON
M5J 2T6

  • This field is for validation purposes and should be left unchanged.
By providing your e-mail address, you are consenting to receive press releases and other information concerning NeuPath Health Inc. and its affiliates and partners. You may withdraw your consent at any time.